Among the assigned down-regulated pathways in NASH-HCC compared to NASH patients were necroptosis, amino acid metabolism, regulation of lipid metabolism by PPAR-α, biogenic amine synthesis, fatty acid metabolism, and mTOR signaling pathway (Figure 7B). The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatohepatitis.